Diagnosis and Treatment > Signs and Symptoms

You are looking at 1 - 2 of 2 items for :

  • Erectile dysfunction x
  • Hypothyroidism x
Clear All
Carlos Tavares Bello Endocrinology Department, Hospital de Egas Moniz, Lisbon, Portugal

Search for other papers by Carlos Tavares Bello in
Google Scholar
PubMed
Close
,
Patricia Cipriano
Search for other papers by Patricia Cipriano in
Google Scholar
PubMed
Close
,
Vanessa Henriques
Search for other papers by Vanessa Henriques in
Google Scholar
PubMed
Close
,
João Sequeira Duarte
Search for other papers by João Sequeira Duarte in
Google Scholar
PubMed
Close
, and
Conceição Canas Marques
Search for other papers by Conceição Canas Marques in
Google Scholar
PubMed
Close

Summary

Granular cell tumours (GCT) are rare, slow-growing, benign neoplasms that are usually located in the head and neck. They are more frequent in the female gender and typically have an asymptomatic clinical course, being diagnosed only at autopsy. Symptomatic GCT of the neurohypophysis are exceedingly rare, being less than 70 cases described so far. The authors report on a case of a 28-year-old male that presented to the Endocrinology clinic with clinical and biochemical evidence of hypogonadism. He also reported minor headaches without any major visual symptoms. Further laboratory tests confirmed hypopituitarism (hypogonadotrophic hypogonadism, central hypothyroidism and hypocortisolism) and central nervous system imaging revealed a pituitary macroadenoma. The patient underwent transcranial pituitary adenoma resection and the pathology report described a GCT of the neurohypophysis with low mitotic index. The reported case is noteworthy for the rarity of the clinicopathological entity.

Learning points:

  • Symptomatic GCTs are rare CNS tumours whose cell of origin is not well defined that usually give rise to visual symptoms, headache and endocrine dysfunction.

  • Imaging is quite unspecific and diagnosis is difficult to establish preoperatively.

  • Surgical excision is challenging due to lesion’s high vascularity and propensity to adhere to adjacent structures.

  • The reported case is noteworthy for the rarity of the clinicopathological entity.

Open access
Ana G Ferreira Endocrinology and Diabetes Department, Garcia de Orta Hospital, Almada, Portugal

Search for other papers by Ana G Ferreira in
Google Scholar
PubMed
Close
,
Tiago N Silva Endocrinology and Diabetes Department, Garcia de Orta Hospital, Almada, Portugal

Search for other papers by Tiago N Silva in
Google Scholar
PubMed
Close
,
Henrique V Luiz Endocrinology and Diabetes Department, Garcia de Orta Hospital, Almada, Portugal

Search for other papers by Henrique V Luiz in
Google Scholar
PubMed
Close
,
Filipa D Campos Hemato-Oncology Department, Garcia de Orta Hospital, Almada, Portugal

Search for other papers by Filipa D Campos in
Google Scholar
PubMed
Close
,
Maria C Cordeiro Endocrinology and Diabetes Department, Garcia de Orta Hospital, Almada, Portugal

Search for other papers by Maria C Cordeiro in
Google Scholar
PubMed
Close
, and
Jorge R Portugal Endocrinology and Diabetes Department, Garcia de Orta Hospital, Almada, Portugal

Search for other papers by Jorge R Portugal in
Google Scholar
PubMed
Close

Sellar plasmacytomas are rare and the differential diagnosis with non-functioning pituitary adenomas might be difficult because of clinical and radiological resemblance. They usually present with neurological signs and intact anterior pituitary function. Some may already have or eventually progress to multiple myeloma. We describe a case associated with extensive anterior pituitary involvement, which is a rare form of presentation. A 68-year-old man was referred to our Endocrinology outpatient clinic due to gynecomastia, reduced libido and sexual impotence. Physical examination, breast ultrasound and mammography confirmed bilateral gynecomastia. Blood tests revealed slight hyperprolactinemia, low testosterone levels, low cortisol levels and central hypothyroidism. Sellar MRI showed a heterogeneous sellar mass (56 × 60 × 61 mm), initially suspected as an invasive macroadenoma. After correcting the pituitary deficits with hydrocortisone and levothyroxine, the patient underwent transsphenoidal surgery. Histological examination revealed a plasmacytoma and multiple myeloma was ruled out. The patient was unsuccessfully treated with radiation therapy (no tumor shrinkage). Myeloma ultimately developed, with several other similar lesions in different locations. The patient was started on chemotherapy, had a bone marrow transplant and is now stable (progression free) on lenalidomide and dexamethasone. The presenting symptoms and panhypopituitarism persisted, requiring chronic replacement treatment with levothyroxine, hydrocortisone and testosterone.

Learning points:

  • Plasmacytomas, although rare, are a possible type of sellar masses, which have a completely different treatment approach, so it is important to make the correct diagnosis.

  • Usually, they present with neurological signs and symptoms and a well-preserved pituitary function, but our case shows that anterior pituitary function can be severely compromised.

  • Making a more extensive evaluation (clinical and biochemical) might provide some clues to this diagnosis.

Open access